According to a diabetes study published in medical journal The Lancet, diabetes drug Victoza is more effective than Januvia at reducing blood glucose levels amongst patients with type 2 diabetes . The study involved patients who had previously not responded to treatment to common diabetes drug Metformin .
The study, which was funded by the manufacturers of Victoza, Novo Nordisk, reportedly: “followed other positive comparative studies and would bolster Victoza’s reputation among medical experts.”
The study was research by Dr. Richard Pratley, the director of Diabetes and Metabolism Translational Medicine Unit at the University of Vermont College of Medicine, reportedly commented: “With so many patients still struggling to lower their blood sugar, Victoza represents an effective new option.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…